Skip to main content
Bladder Cancer logoLink to Bladder Cancer
. 2021 Mar 19;7(1):111–112. doi: 10.3233/BLC-219501

Outcomes of Trimodal Therapy for cT2-3 Urothelial Carcinoma in a Racially Diverse Population: A Single Institution Experience in the Bronx

PMCID: PMC8080894  PMID: 33999040

Josh Gottlieb, Evan Kovac, Ahmed Aboumohamed, Mark Schoenberg, Benjamin Gartrell, William Bodner, Chandan Guha, Keyur Mehta, Madhur Garg, Alexander Sankin

[Bladder Cancer, 6(4) (2020), 453–460, 10.3233/BLC-200332]

https://content.iospress.com/articles/bladder-cancer/blc200332

In the funding section on page 459 the authors have reported no sources of funding related to this article. However, this is incorrect and the funding details should specified in the funding section with the following text: Grant support for A. Sankin provided by NIH LRP (L30 CA220768), 7/2017 – 6/2020.

As such, the updated Funding section, as well as the sections of Acknowledgements, Author Contributions and Conflicts of Interest of this article are provided below.

ACKNOWLEDGMENTS

The authors have no acknowledgments.

FUNDING

Grant support for A. Sankin provided by NIH LRP (L30 CA220768), 7/2017 – 6/2020

AUTHOR CONTRIBUTIONS

Collection and Assembly of Data: Gottlieb

Study Concept and Design: Sankin, Kovac, Schoenberg

Statistical Analysis: Kovac, Gottlieb

Analysis and Interpretation of Data: Sankin, Kovac, Gottlieb

Drafting of Manuscripts: Gottlieb, Sankin Manuscript Revision: Sankin, Kovac, Schoenberg, Aboumohamed, Gartrell, Bodner, Garg

Final Approval of Manuscript: All authors

CONFLICTS OF INTEREST

The authors have no conflicts of interest.


Articles from Bladder Cancer are provided here courtesy of SAGE Publications

RESOURCES